Talampanel (GYKI 53773) chemical structure
Chemical structureResearch use only
CAT. NO. DC7863Featured

Talampanel (GYKI 53773)

Pack Sizes & Prices

TotalUS$550
We match the best price and quality on market.
Product overview

Description & Application

Talampanel is a potent and selective AMPA-receptor antagonist, is a potential new antiepileptic drug (AED).

ParameterValue
Chemical Name1-[(8R)-5-(4-aminophenyl)-8-methyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-7-yl]ethanone
CAS No.161832-65-1
SynonymsAmpanel, Kinampa, Talampanel (INN), GYKI 53773, AC1L4UWP, AC1Q5KPR
FormulaC19H19N3O3
M.Wt337.372
SMILESC[C@@H]1CC2=C(C=C3OCOC3=C2)C(C4=CC=C(N)C=C4)=NN1C(C)=O
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

Talampanel is a potent and selective AMPA-receptor antagonist, is a potential new antiepileptic drug (AED).

In Vitro

Talampanel is a glutamate receptor inhibitor with anti-seizure activity.

In Vivo

Talampanel reduces motoneuronal calcium in a mouse model of ALS, but its effi cacy declines as the disease progresses, suggesting that medication initiation in the earlier stages of the disease might be more effective. [2]

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Product documentation

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Solution calculator

Related research products

MDL 29951 chemical structureDC7194

MDL 29951

MDL-29951 is a novel glycine antagonist of NMDA receptor activation, with Ki of 0.14 μM for [3H]glycine binding in vitro and in vivo.

View activity & prices
CIQ chemical structureDC8156

CIQ

CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit. IC50 value: 2.7 μM (EC50, for NR2C) and 2.8 μM (EC50, NR2D)Target: NMDA receptorCIQ increases channel opening frequency of…

View activity & prices
BDP-12(Ampalex) chemical structureDC5075

BDP-12(Ampalex)

Ampalex (Ampakine CX516; CX516; BDP 12) is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator as a treatment for Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI).

View activity & prices
Perampanel(E2007) chemical structureDC7226

Perampanel(E2007)

Perampanel(E2007; ER 155055-90) is a selective noncompetitive AMPA-type glutamate receptor antagonist which has demonstrated anticonvulsant activity in experimental seizure models and antiepileptic activity in clinical…

View activity & prices
PEPA chemical structureDC7989

PEPA

PEPA is an allosteric modulator of AMPA receptors; binds to the GluA2o and GluA3o LBDs and can be utilized as an indicator of AMPA receptor heterogeneity.

View activity & prices
DNQX chemical structureDC10672

DNQX

DNQX is a AMPA receptor antagonists.target: AMPA receptorIn vitro: DNQX, added 2 h after cell plating, induces a dose-dependent neurotoxicity.

View activity & prices

Cart

Request quotation